The financial impact of all cases of mastitis on U.S. dairies amounts to over $2 billion annually, with losses attributed to treatment costs, milk loss, milk withholds and decreases in reproductive efficiency. Research indicates that these costs can be reduced without appreciable negative outcomes by selectively treating non-severe cases, rather than treating all cases with antibiotics.